Telemedicine medical abortion service in Georgia: an evaluation of a strategy with reduced number of in-Clinic visits.
Eur J Contracept Reprod Health Care
; 28(2): 141-146, 2023 Apr.
Article
in English
| MEDLINE | ID: covidwho-2311365
ABSTRACT
PURPOSE:
To evaluate feasibility and acceptability of a medical abortion service that offers a telemedicine visit (in place of an in-person visit) during a mandatory waiting period, and at-home follow-up with the use of multi-level pregnancy tests (MLPT).METHODS:
Participants were screened for eligibility in clinic, and during the waiting period, received a telephone call to confirm desire to proceed with the service. Participants were mailed a study package containing mifepristone, misoprostol, two multi-level pregnancy tests, and instructions for their use. Follow-up consultation took place by phone to evaluate abortion completeness. The analysis was descriptive.RESULTS:
One-hundred twenty-two participants were enrolled in the study, and 120 chose to proceed with the abortion after the waiting period and were sent a study package. One participant was lost to follow up. The majority of participants did not experience problems receiving the study package (94.1%, n = 112), took mifepristone (100%, n = 119), misoprostol (99.2%, n = 118), and MLPTs (99.1%, n = 116) as instructed, and forwent additional clinic visits (91.6%, n = 109). All participants were satisfied with the service. Most participants had a complete abortion without a procedure (95.8%, n = 114).CONCLUSIONS:
The adapted telemedicine medical abortion service was feasible and satisfactory to participants and has the potential to make medical abortion more patient-centered where waiting periods are mandated.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Misoprostol
/
Telemedicine
Type of study:
Cohort study
/
Experimental Studies
/
Observational study
/
Prognostic study
Limits:
Female
/
Humans
/
Pregnancy
Country/Region as subject:
North America
Language:
English
Journal:
Eur J Contracept Reprod Health Care
Journal subject:
Reproductive Medicine
/
Family Planning Services
Year:
2023
Document Type:
Article
Affiliation country:
13625187.2023.2170710
Similar
MEDLINE
...
LILACS
LIS